-
COMPARING PATIENT PERSPECTIVES AND HTA REQUIREMENTS IN HEALTH ECONOMIC MODELING: A MULTIPLE SCLEROSIS PERSPECTIVE
Aug 11, 2026, 17:16 PM -
REAL-WORLD UTILIZATION, EXPENDITURES, AND CARDIOVASCULAR EVENTS AMONG USERS OF SGLT-2 INHIBITORS AND GLP-1 RECEPTOR AGONISTS IN US ADULTS WITH TYPE 2 DIABETES
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT ANALYSIS OF EVOQUE TRANSCATHETER TRICUSPID VALVE REPLACEMENT FOR SEVERE SYMPTOMATIC TRICUSPID REGURGITATION FROM THE FRENCH HEALTHCARE PAYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
DO CHILDREN AGREE WITH CAREGIVERS ON PERCEIVED HEALTH? EXPLORING DISCREPANCIES BETWEEN SELF-REPORTED AND PROXY-REPORTED HEALTH STATUS IN CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
Aug 11, 2026, 17:16 PM -
WHICH GOALS CAN WE MEASURE? THE EVALUABILITY OF EU HTA REGULATION OBJECTIVES
Aug 11, 2026, 17:16 PM -
TUMOR STABILIZATION AND LONG-TERM IGF-1 NORMALIZATION RATE WITH PASIREOTIDE LAR AND PEGVISOMANT IN REAL-WORLD SECOND-LINE ACROMEGALY TREATMENT
Aug 11, 2026, 17:16 PM -
WHAT DOES IT TAKE TO ATTAIN ASMR - I/II IN FRANCE: REVIEW OF HTA ASSESSMENTS IN ONCOLOGY
Aug 11, 2026, 17:16 PM -
RETURN ON INVESTMENT OF GLP-1/GIP THERAPY FOR OBESITY IN BULGARIA
Aug 11, 2026, 17:16 PM -
ALCOHOL USE DISORDER (AUD) SCREENING FOLLOWS DIAGNOSIS RATHER THAN PRECEDING IT: EVIDENCE OF SYSTEMIC WORKFLOW GAPS FROM NORSTELLALINQ REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
RETURN ON INVESTMENT OF THE UNPLUGGED PROGRAM: A COST-BENEFIT ANALYSIS OF A SCHOOL-BASED SUBSTANCE USE PREVENTION PROGRAM IN FRANCE
Aug 11, 2026, 17:16 PM -
CONTROLLING FOR WHAT COMES NEXT: ESTIMATING GENERALIZED DIRECT EFFECTS OF FIRST-LINE THERAPY ON REAL-WORLD OVERALL SURVIVAL USING COUNTERFACTUAL SECOND-LINE DISTRIBUTIONS IN ADVANCED NON-SMALL CELL LUNG CANCER
Aug 11, 2026, 17:16 PM -
MODELING THERAPEUTIC PERSISTENCE IN OCULAR THERAPIES: A REVIEW OF HTA SUBMISSIONS
Aug 11, 2026, 17:16 PM -
FINANCIAL BURDEN OF PRADER-WILLI SYNDROME: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
TEMPORAL TRENDS IN ICD-10-CM OBESITY CODING ACCURACY, 2021-2025: EVIDENCE FROM THE NORSTELLALINQ LINKED CLAIMS AND EHR DATABASE
Aug 11, 2026, 17:16 PM -
INVESTIGATING THE IMPACT OF HERPES ZOSTER ON QUALITY OF LIFE AND WORK PRODUCTIVITY AMONG PATIENTS IN SPAIN
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGICAL BURDEN, HEALTHCARE RESOURCE UTILIZATION, AND SURVIVAL AMONG PATIENTS WITH ACUTE ISCHEMIC STROKE IN THE BRAZILIAN PRIVATE HEALTH SYSTEM: A REAL-WORLD RETROSPECTIVE COHORT
Aug 11, 2026, 17:16 PM -
TREATMENT SEQUENCING AND LINE-OF-THERAPY PATTERNS IN THE BTKI ERA: REAL-WORLD EVIDENCE FROM 24,410 CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS USING NORSTELLALINQ
Aug 11, 2026, 17:16 PM -
NEGOTIATED CLOSED BUDGETS AND GENERIC ENTRY IN ORAL ANTICOAGULANTS IN GREECE, 2021-2025: IMPROVING PATIENT ACCESS WHILE CONTAINING PHARMACEUTICAL EXPENDITURE
Aug 11, 2026, 17:16 PM -
EXPLORING THE IMPACT OF GENERIC SUBSTITUTION AND INSURANCE DRUG FORMULARY POLICIES ON MEDICATION COVERAGE DECISIONS AND PRESCRIBING IN SAUDI ARABIA PRIVATE HEALTHCARE SECTOR
Aug 11, 2026, 17:16 PM -
GENDER GAP IN MEDICINE AFFORDABILITY - NATIONWIDE EVIDENCE FROM FINLAND
Aug 11, 2026, 17:16 PM
